CHWWF Stock UPDATES Chesswood Group (CHWWF) 14.0472 08/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chesswood Group (CHWWF) 14.0472 $CHWWF

Chesswood Renews Normal Course Issuer Bid
Marketwire - Thu Aug 21, 1:15PM CDT
Chesswood Group Limited ("Chesswood" (TSX: CHW) announced today that the Toronto Stock Exchange (the "TSX" has accepted its notice of intention to conduct a normal course issuer bid to enable it to purchase up to 746,331 of its 10,373,932 Common Shares ("Shares" outstanding, representing approximately 10 per cent of Chesswood's public float of 7,463,312 Shares as of August 12, 2014. The average daily trading volume of Chesswood for the past six months was 20,569, and a maximum of 5,142 Shares (being 25% of the average daily trading volume) may be purchased by Chesswood on any one day under its normal course issuer bid, except where purchases are made in accordance with "block purchases" exemptions under applicable TSX policies.

Chesswood Group Limited Announces August 2014 Dividend
Marketwire - Wed Aug 20, 6:01AM CDT
Chesswood Group Limited (TSX: CHW) announced today a cash dividend of $0.065 per share for the month of August. The dividend will be payable to shareholders of record at the close of business on August 29, 2014 and will be paid on September 15, 2014.

Chesswood Announces Results for Q2 2014
Marketwire - Thu Aug 07, 6:55AM CDT
Chesswood Group Limited (the "Company" (TSX: CHW), announced today its results for the three and six-month periods ended June 30th, 2014.

Chesswood Group Limited Announces July 2014 Dividend
Marketwire - Tue Jul 22, 6:01AM CDT
Chesswood Group Limited (TSX: CHW) announced today a cash dividend of $0.065 per share for the month of July. The dividend will be payable to shareholders of record at the close of business on July 31, 2014 and will be paid on August 15, 2014.

Chesswood Group Limited Announces March 2014 Dividend
Marketwire - Thu Mar 20, 7:18AM CDT
Chesswood Group Limited (TSX: CHW) announced today a cash dividend of $0.065 per share for the month of March. The dividend will be payable to shareholders of record at the close of business on March 31, 2014 and will be paid on April 15, 2014.

Chesswood Announces Results for 2013
Marketwire - Thu Mar 13, 6:55AM CDT
Chesswood Group Limited (the "Company" or "Chesswood" (TSX: CHW) announced today its results for the year ended December 31, 2013.

Chesswood Group Limited Announces February 2014 Dividend
Marketwire - Thu Feb 20, 6:01AM CST
Chesswood Group Limited (TSX: CHW) announced today a cash dividend of $0.065 per share for the month of February. The dividend will be payable to shareholders of record at the close of business on February 28, 2014 and will be paid on March 17, 2014.

Chesswood Announces the Purchase of Northstar Leasing
Marketwire - Mon Feb 03, 6:01AM CST
Chesswood Group Limited ("Chesswood" (TSX: CHW) is pleased to announce that it has completed the purchase of all of the outstanding shares of Northstar Leasing Corporation ("Northstar" , a long-standing non-prime commercial equipment finance company, located in Barrie, Ontario.

Chesswood Group Limited Announces January 2014 Dividend
Marketwire - Wed Jan 22, 7:04AM CST
Chesswood Group Limited (TSX: CHW) announced today a cash dividend of $0.065 per share for the month of January. The dividend will be payable to shareholders of record at the close of business on January 31, 2014 and will be paid on February 18, 2014.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Middle East Tensions and the Vance-Walz Debate

Updated Category News Views 71

Market Reactions to Middle East Tensions US stock futures are experiencing a downward trend as investors react to the escalating violence in the Middle East. With Iran claiming to have ceased its air bombardments on Israel, uncertainty still looms, as Israeli officials pledge a counterattack. This ongoing conflict has already impacted Wall Street, where equity values...

Continue Reading
Class Action Alert for Visa Inc. Shareholders Facing Losses

Updated Category News Views 91

Class Action Notification for Visa Inc. Shareholders The Gross Law Firm is reaching out to shareholders of Visa Inc. (NYSE: V) regarding an important class action that may affect them. If you purchased shares during a specific class period and have suffered losses, your participation could be significant in holding the company accountable. Understanding the Class Period...

Continue Reading
Coca-Cola's Earnings Report: Anticipated Insights and Analysis

Updated Category News Views 205

Coca-Cola's Earnings Report Overview The Coca-Cola Company (NYSE: KO) is on the cusp of unveiling its second-quarter financial results. Investors, analysts, and fans alike are closely watching what insights the beverage giant will provide during this crucial report. With notable figures in the U.S. market keeping an eye on Coca-Cola, the anticipation is palpable. Earnings...

Continue Reading
Maggiano's Unveils Gourmet Italian-American Classics Menu

Updated Category News Views 410

Introduction of Italian-American Classics at Maggiano's Maggiano's Little Italy is embracing the culinary heritage of Italian-American cuisine by introducing a new menu that reflects a dedication to high-quality ingredients and gourmet recipes. Under the expert guidance of award-winning Chef Anthony Amoroso, the restaurant's latest offerings promise to impress food...

Continue Reading
Recognizing Excellence: Pierce & O'Neill Founders Honored

Updated Category News Views 362

Pierce & O’Neill Founders Honored Among Top Attorneys Pierce & O’Neill, LLP, a renowned litigation boutique, is celebrating its founders, Jesse Pierce and Jack O’Neill, for their remarkable achievements in the legal field. Recently recognized in Lawdragon’s prestigious list of the 500 Leading Lawyers in America for 2025, this accolade showcases their exceptional...

Continue Reading